一个真实的世界药监测研究的埃斯凯他明鼻喷雾
Yaqing Chen1, Hangye Gu, Wenwei Li
1Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
Medicine
|September 10, 2024
概括
这项研究分析了5132份关于埃斯基坦胺鼻喷剂的不良药物事件报告,确定了常见的副作用,如解离和镇静,以及新的安全信号,如间歇性囊炎和药物滥用.
科学领域:
- 药物监督 药物监督 药物监督
- 药物安全监测监测 药物安全监测
- 临床药理学 临床药理学
背景情况:
- 营销后监测对于监测药物安全至关重要.
- 埃斯凯他鼻喷雾用于特定的医疗条件,需要持续的安全评估.
- 识别药物不良事件 (ADEs) 可以确保临床使用期间的患者安全.
研究的目的:
- 挖掘和更新ESKETAMINE鼻喷雾的营销后安全信号.
- 识别新的不良药物事件 (ADE) 信号并改善药物监测.
- 通过对临床使用数据的严格分析,增强患者安全.
主要方法:
- 分析了2019年第一季度至2023年第二季度的美国食品和药物管理局不良事件报告系统 (FAERS) 的数据.
- 采用了不成比例方法,包括报告赔率比率 (ROR),比例报告比率 (PRR),多项目马鱼缩小器 (MGPS) 和贝叶斯信任传播神经网络 (BCPNN).
- 使用医学监管活动词典 (MedDRA) 首选术语 (26.0版本) 和系统器官分类 (SOC) 的标准化ADE描述.
主要成果:
- 总共有5132份ADE报告列出了埃斯凯他明鼻雾剂作为主要的可疑药物.
- 观察到的最常见的ADEs是解离,镇静和高血压.
- 发现了新的,罕见的安全信号,包括间歇性囊炎,药物滥用和药物转移.
结论:
- 这项研究成功地确定了埃斯基坦胺鼻雾剂的显著新的ADE信号.
- 这些发现为医疗保健专业人员在评估患者症状和风险时提供了宝贵的信息.
- 加强药物监测有助于更安全的临床应用埃斯基坦胺鼻喷雾剂.
相关概念视频
01:19Pharmacovigilance
788
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
788
01:20Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149